Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2‐adrenoceptor antagonist MK‐467 in horses

A de Vries, SAE Pakkanen, MR Raekallio… - Veterinary anaesthesia …, 2016 - Elsevier
Objectives To investigate the effects of MK‐467 on sedation quality, and cardiopulmonary
and pharmacokinetic variables in horses sedated intravenously (IV) with romifidine. Study …
被引用次数：46 相关文章

[引用][C] Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2-adrenoceptor antagonist MK-467 in horses.

A de Vries, SAE Pakkanen… - Veterinary …, 2016 - researchportal.helsinki.fi
Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2 -adrenoceptor
antagonist MK-467 in horses. — University of Helsinki Skip to main navigation Skip to search …

Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2‐adrenoceptor antagonist MK‐467 in horses

A Vries, SAE Pakkanen, MR Raekallio, A Ekiri… - Veterinary Anaesthesia …, 2016 - infona.pl
Objectives To investigate the effects of MK‐467 on sedation quality, and cardiopulmonary
and pharmacokinetic variables in horses sedated intravenously (IV) with romifidine. Study …

Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2‐adrenoceptor antagonist MK‐467 in horses

A de Vries, SAE Pakkanen, MR Raekallio… - Veterinary …, 2016 - vaajournal.org
Objectives To investigate the effects of MK‐467 on sedation quality, and cardiopulmonary
and pharmacokinetic variables in horses sedated intravenously (IV) with romifidine. Study …

Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2-adrenoceptor antagonist MK-467 in horses.

A de Vries, SA Pakkanen, MR Raekallio… - Veterinary …, 2016 - madbarn.com
To investigate the effects of MK-467 on sedation quality, and cardiopulmonary and
pharmacokinetic variables in horses sedated intravenously (IV) with romifidine. Methods …

Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2‐adrenoceptor antagonist MK‐467 in horses

A de Vries, SA Pakkanen… - Veterinary …, 2016 - openresearch.surrey.ac.uk
Abstract horses MK‐467 peripheral antagonist sedation α2‐agonist alpha 2 adrenergic
receptor stimulating agent anesthetic agent hypnotic sedative agent imidazole derivative n …

Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2-adrenoceptor antagonist MK-467 in horses

A de Vries, SA Pakkanen, MR Raekallio, A Ekiri… - 2016 - pubmed.ncbi.nlm.nih.gov
Objectives To investigate the effects of MK-467 on sedation quality, and cardiopulmonary
and pharmacokinetic variables in horses sedated intravenously (IV) with romifidine. Study …

Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2-adrenoceptor antagonist MK-467 in horses.

A Vries, SAE Pakkanen, MR Raekallio, A Ekiri… - 2016 - cabidigitallibrary.org
Objectives: To investigate the effects of MK-467 on sedation quality, and cardiopulmonary
and pharmacokinetic variables in horses sedated intravenously (IV) with romifidine. Study …

Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2 -adrenoceptor antagonist MK-467 in horses.

A de Vries, SA Pakkanen, MR Raekallio… - Veterinary …, 2016 - europepmc.org
Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2 -adrenoceptor
antagonist MK-467 in horses. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Clinical effects and pharmacokinetic variables of romifidine and the peripheral α2‐adrenoceptor antagonist MK‐467 in horses

A de Vries, SAE Pakkanen… - Veterinary …, 2016 - Wiley Online Library
Objectives To investigate the effects of MK‐467 on sedation quality, and cardiopulmonary
and pharmacokinetic variables in horses sedated intravenously (IV) with romifidine. Study …